To estimate the burden of malarial disease, and evaluate the likely effects of control
strategies, requires reliable predictions of malaria transmission intensity. It has long been …

Malaria is a leading cause of mortality and morbidity globally, and effective vaccines are
urgently needed. Malaria vaccine approaches can be broadly grouped as pre‐erythrocytic …

Individuals living in areas where malaria is endemic are repeatedly exposed to many
different malaria parasite antigens. Studies on naturally acquired antibody-mediated …

Antibodies can protect from Plasmodium falciparum (Pf) infection and clinical malaria
disease. However, in the absence of constant reexposure, serum immunoglobulin (Ig) levels …

Substantial evidence indicates that antibodies to Plasmodium falciparum merozoite antigens
play a role in protection from malaria, although the precise targets and mechanisms …

Individuals in areas of Plasmodium falciparum endemicity develop immunity to malaria after
repeated exposure. Knowledge of the acquisition and nature of protective immune …

Background Blood spots collected onto filter paper are an established and convenient
source of antibodies for serological diagnosis and epidemiological surveys. Although …

Acquisition of partially protective immunity is a dominant feature of the epidemiology of
malaria among exposed individuals. The processes that determine the acquisition of …

Background. Acquired immune responses to malaria have widely been perceived to be
short-lived, with previously immune individuals losing immunity when they move from …

Naturally acquired antibody responses provide partial protection from clinical malaria, and
blood-stage parasite vaccines under development aim to prime such responses. To …